Physician profile
Joann Hanchar
NPI 1811313109
$2,482.37
in general payments reported to CMS, 2019-2025
13 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $291 · 2022: $255 · 2023: $628 · 2024: $823 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,936.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $842.35 | 2021-2025 | Jardiance |
| Abbott Laboratories | $572.38 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $474.95 | 2023-2025 | Brilinta, Farxiga, Wainua |
| Bayer Healthcare Pharmaceuticals INC. | $127.52 | 2025 | |
| Novartis Pharmaceuticals Corporation | $124.86 | 2021-2025 | |
| Boston Scientific Corporation | $111.25 | 2023 | Watchman Flx |
| Pfizer INC. | $71.55 | 2024 | |
| Janssen Pharmaceuticals, INC | $49.99 | 2022 | |
| Merck Sharp & Dohme LLC | $32.70 | 2024 | Verquvo |
| Vifor Pharma, INC. | $25.41 | 2022 | |
| Medtronic, INC. | $18.94 | 2024 | Cardiosight Reader |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.89 | 2021 | |
| Cvrx, INC. | $12.58 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joann Hanchar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.